Leukemia, Erythroblastic, Acute

Also known as: Erythroleukaemia / Acute erythroid leukemia / Erythroleukemia / Acute erythroid leukemia, not having achieved remission / Acute erythroid leukaemia / Myelosis erythraemic / Syndrome DiGuglielmo's / Di Guglielmo's syndrome / Disorder: Erythroleukemia, FAB M6 (disorder) / Acute erythroid leukemia (morphologic abnormality) / Erythraemic myelosis / Myelosis erythremic / Erythremic myelosis

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00987Cytarabine1Withdrawn1
DB01177Idarubicin1Withdrawn1
DB12062Volasertib1Withdrawn1
DB00041Aldesleukin1 / 2Completed1
DB00928Azacitidine1 / 2Active Not Recruiting1
DB01008Busulfan1 / 2Completed1
DB01073Fludarabine1 / 2Completed1
DB15721Natural Killer Cell1 / 2Completed1
DB02546Vorinostat1 / 2Active Not Recruiting1
DB00087Alemtuzumab2Completed1
DB00928Azacitidine2Completed1
DB00531Cyclophosphamide2Recruiting1
DB18722Dilanubicel2Recruiting1
DB01073Fludarabine2Completed1
DB01073Fludarabine2Recruiting1
DB01042Melphalan2Completed1
DB04572Thiotepa2Recruiting1